GPC1, glypican 1, 2817

N. diseases: 96; N. variants: 3
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE Mir-149 rs2292832 was not associated with cancer risk in overall population and there were no differences between Asians and Caucasians. 30930933 2019
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE Mir-149 rs2292832 was not associated with cancer risk in overall population and there were no differences between Asians and Caucasians. 30930933 2019
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE Overall, significant association between miR-149 rs2292832 and susceptibility to cancer was identified in a recessive genetic model, TT/ (TC + CC) (OR = 1.19, 95% CI = 1.02-1.39, P = 0.02). 30447914 2018
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE It was shown that 6 miRNAs SNPs (miR-608 rs4919510, miR-492 rs2289030, miR-378 rs1076064, miR-499 rs4919510, miR-149 rs2292832, miR-196a2 rs11614913) were associated with better cancer overall survival (OS) while let-7i rs10877887 was associated with poor OS; the homozygous and heterozygote genotype of miR-423 were related to poor cancer relapse-free survival (RFS) when compared with the wild genotype; miR-146 rs2910164 was linked to favorable cancer DFS while miR-196a2 rs11614913 was associated with poor DFS. 30619739 2018
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE Overall, significant association between miR-149 rs2292832 and susceptibility to cancer was identified in a recessive genetic model, TT/ (TC + CC) (OR = 1.19, 95% CI = 1.02-1.39, P = 0.02). 30447914 2018
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE It was shown that 6 miRNAs SNPs (miR-608 rs4919510, miR-492 rs2289030, miR-378 rs1076064, miR-499 rs4919510, miR-149 rs2292832, miR-196a2 rs11614913) were associated with better cancer overall survival (OS) while let-7i rs10877887 was associated with poor OS; the homozygous and heterozygote genotype of miR-423 were related to poor cancer relapse-free survival (RFS) when compared with the wild genotype; miR-146 rs2910164 was linked to favorable cancer DFS while miR-196a2 rs11614913 was associated with poor DFS. 30619739 2018
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE When all the eligible studies were pooled into this meta-analysis, a significant association between MIR-149 gene rs2292832 polymorphism and hepatocellular carcinoma risk was found, while no association was found between this gene polymorphism and overall cancer risk. 27348444 2016
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE When all the eligible studies were pooled into this meta-analysis, a significant association between MIR-149 gene rs2292832 polymorphism and hepatocellular carcinoma risk was found, while no association was found between this gene polymorphism and overall cancer risk. 27348444 2016
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE Overall, the results demonstrated that the rs2292832 polymorphism was subtly decrease the risk of breast cancer (CT + CC vs TT: OR = 0.83, 95% CI: 0.70-0.98, P = 0.03; CC vs CT + TT: OR = 0.80, 95% CI: 0.68-0.93, P = 0.00), and the rs895819 polymorphism wasassociated with significantly increased cancer risk in the Asian population (AG + GG vs AA: OR = 1.24, 95% CI: 1.03-1.50, P = 0.02) and in colorectal cancer subgroup (GG vs AA: OR = 1.45, 95% CI: 1.10-1.92, P = 0.00; AG + GG vs AA: OR = 1.35, 95% CI: 1.15-1.58, P = 0.00; GG vs AG + AA: OR = 1.36, 95% CI: 1.04-1.77, P = 0.02). 26993779 2016
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE Overall, the results demonstrated that the rs2292832 polymorphism was subtly decrease the risk of breast cancer (CT + CC vs TT: OR = 0.83, 95% CI: 0.70-0.98, P = 0.03; CC vs CT + TT: OR = 0.80, 95% CI: 0.68-0.93, P = 0.00), and the rs895819 polymorphism wasassociated with significantly increased cancer risk in the Asian population (AG + GG vs AA: OR = 1.24, 95% CI: 1.03-1.50, P = 0.02) and in colorectal cancer subgroup (GG vs AA: OR = 1.45, 95% CI: 1.10-1.92, P = 0.00; AG + GG vs AA: OR = 1.35, 95% CI: 1.15-1.58, P = 0.00; GG vs AG + AA: OR = 1.36, 95% CI: 1.04-1.77, P = 0.02). 26993779 2016
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE For the rs2292832 polymorphism, the results showed no significant risk association in both overall pooled analysis and subgroup of cancer types, smoking status, gender and tea drinking status in the Chinese population. 23725137 2013
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE In summary, miR-196a2 rs11614913, miR-146a rs2910164, and miR-499 rs3746444 are risk factors for cancer development, whereas mir-149 rs2292832 and miR-27a rs895919 are not associated with cancer risk. 24278149 2013
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE For the rs2292832 polymorphism, the results showed no significant risk association in both overall pooled analysis and subgroup of cancer types, smoking status, gender and tea drinking status in the Chinese population. 23725137 2013
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE Results of this meta-analysis suggest that the hsa-miR-149 rs2292832 polymorphism is not associated with cancer risk in spite of the potentially protective role of C allele in hepatocellular carcinoma and male gastric cancer. 24040059 2013
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE Results of this meta-analysis suggest that the hsa-miR-149 rs2292832 polymorphism is not associated with cancer risk in spite of the potentially protective role of C allele in hepatocellular carcinoma and male gastric cancer. 24040059 2013
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE In summary, miR-196a2 rs11614913, miR-146a rs2910164, and miR-499 rs3746444 are risk factors for cancer development, whereas mir-149 rs2292832 and miR-27a rs895919 are not associated with cancer risk. 24278149 2013
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. 23155448 2012
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. 23155448 2012
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE The present study was aimed to investigate the association between four highly studied miRNA polymorphisms (mir-146a rs2910164, mir-196a2 rs11614913, mir-149 rs2292832 and mir-499 rs3746444) and cancer risk by using a two-sided meta-analytic approach. 23226435 2012
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE The present study was aimed to investigate the association between four highly studied miRNA polymorphisms (mir-146a rs2910164, mir-196a2 rs11614913, mir-149 rs2292832 and mir-499 rs3746444) and cancer risk by using a two-sided meta-analytic approach. 23226435 2012
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0006826
Disease:
Malignant Neoplasms
0.100 GeneticVariation BEFREE Here, we evaluated 101 paired samples (cancer and normal tissues) from non-small cell lung carcinoma (NSCLC) patients to study the genotype distribution of single nucleotide polymorphisms (SNPs) in miR-146a (rs2910164 C-G), miR-149 (rs2292832 C-T), miR-196a2 (rs11614913 C-T) and miR-499 (rs3746444 G-A) and their influence on the expression of respective miRNAs. 21902575 2011
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C1306459
Disease:
Primary malignant neoplasm
0.100 GeneticVariation BEFREE Here, we evaluated 101 paired samples (cancer and normal tissues) from non-small cell lung carcinoma (NSCLC) patients to study the genotype distribution of single nucleotide polymorphisms (SNPs) in miR-146a (rs2910164 C-G), miR-149 (rs2292832 C-T), miR-196a2 (rs11614913 C-T) and miR-499 (rs3746444 G-A) and their influence on the expression of respective miRNAs. 21902575 2011
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C2239176
Disease:
Liver carcinoma
0.080 GeneticVariation BEFREE We evaluated the associations of <i>miR-499A</i>>G (rs3746444), <i>miR-149C</i>>T (rs2292832), <i>miR-196a2T</i>>C (rs11614913), and <i>miR-146aG</i>>C (rs2910164) with HCC susceptibility in 100 HCC patients (70 males and 30 females) and 120 healthy controls (70 males and 50 females), using the PCR-restriction fragment length polymorphism method. 30215231 2019
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0009402
Disease:
Colorectal Carcinoma
0.080 GeneticVariation BEFREE Mir-149 rs2292832 may modulate the risk of gastrointestinal tract cancers especially colorectal cancer. 30930933 2019
dbSNP: rs2292832
rs2292832
Entrez Id: 2817;406941;100130449
Gene Symbol: GPC1;MIR149;LOC100130449
GPC1;MIR149;LOC100130449
CUI: C0009402
Disease:
Colorectal Carcinoma
0.080 GeneticVariation BEFREE Hsa-mir-149C/T rs2292832 and hsa-mir-146a G/C rs2910164 may influence CRC risk in an ethnicity-dependent manner by interfering with CRC progression parameters in Tunisian cohort. 29715515 2018